Skip to main content
. 2021 Mar 31;6(6):1525–1536. doi: 10.1016/j.ekir.2021.03.874

Table 2.

Baseline BMD measurements according CKD stages

Skeletal sites CKD stages mGFR Total n = 858 1 - 2
3a
3b
4 - 5
P value
≥ 60 ml/min
45-60 ml/min
30-45 ml/min
< 30 ml/min
n = 156 n = 203 n = 262 n = 237
Femoral neck BMD (g/cm2) 0.87±0.16 0.94 ± 0.17 0.89 ± 0.15 0.87 ± 0.16 0.83 ± 0.14 <0.0001
Z-score 0.20±1.08 0.40±1.16 0.30±1.08 0.26±1.04 -0.11±1.00 <0.0001
T-scorea -0.9(-1.7;-0.01) -0.28(-1.10;0.70) -0.80(-1.60;0.10) -1.00(-1.70;-0.06) -1.28(-1.91;-0.53) <0.0001
Total hip BMD (g/cm2) 0.97±.017 1.02 ± 0.17 0.98 ± 0.17 0.96 ± 0.17 0.93 ± 0.16 <0.0001
Z-score 0.39±1.11 0.50±1.12 0.46±1.08 0.46±1.13 0.18±1.10 <0.05
T-score -0.25±1.22 0.20±1.29 -0.17±1.20 -0.29±1.21 -0.55±1.12 <0.0001
Lumbar spine BMD (g/cm2) 1.08±0.18 1.09 ± 0.17 1.11 ± 0.19 1.08 ± 0.19 1.05 ± 0.18 <0.05
Z-score 0.11±1.54 -0.12±1.42 0.36±1.47 0.20±1.58 -0.06±1.59 <0.01
T-score -0.48±1.58 -0.38±1.50 -0.25±1.59 -0.49±1.66 -0.73±1.48 <0.05
Proximal radius
Hologic BMD (g/cm2) 0.50 ± 0.12 0.51 ± 0.11 0.51 ± 0.10 0.50 ± 0.13 0.50 ± 0.12 0.764b
Z-score 0.59 ± 1.42 0.48 ± 1.36 0.66 ± 1.37 0.72 ± 1.46 0.44 ± 1.45 0.318
T-score -0.60 ± 1.52 -0.46 ± 1.51 -0.51 ± 1.48 -0.54 ± 1.60 -0.77 ± 1.47 0.357
GE-Lunar BMD (g/cm2) 0.89 ± 0.12 0.91 ± 0.11 0.91 ± 0.12 0.88 ± 0.12 0.85 ± 0.15 <0.05
Z-score -0.31 ± 1.08 -0.49 ± 0.98 -0.12 ± 0.99 -0.26 ± 1.11 -0.35 ± 1.23 0.219
T-score -0.76 ± 1.13 -0.57 ± 1.07 -0.61 ± 1.01 -0.87 ± 1.15 -1.03 ± 1.25 <0.05
Bone statusc normal (n, %) 473 (56%) 104 (66%) 122 (61%) 139 (53%) 108 (46%) <0.01d
osteopenia (n, %) 283 (33%) 37 (24%) 59 (29%) 94 (36%) 93 (40%)
osteoporosis (n, %) 96 (11%) 15 (10%) 20 (10%) 28 (11%) 33 (14%)

CKD, chronic kidney disease; BMD, bone mineral density; mGFR, measured glomerular filtration rate.

Results are expressed as mean ± SD. An analysis of variance was conducted following by a Tukey’s test as a posteriori multiple comparisons when P value <0.05

a

Median (25ththrough 75thpercentile) compared by a Kruskall-Wallis test following by a Steel-Dwass-Critchlow-Fligner test as a posteriori multiple comparisons when P value <0.05.

b

Aanlysis of variance test with log transformation of the variable.

c

According to World Health Organization definition including T-score at L1-L4 and Total Hip.

d

Chi-square test.